Christopher Ruane has been looking at the UK stock market to try and find shares to buy for his portfolio. Here's one he ...
If you suffered losses exceeding $100,000 in AstraZeneca between between February 23, 2022 and December 17, 2024 and would ...
Gilead continues its divergence out of its original infectious disease beginnings and into cancer and now, more deeply than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback